Long-Term Outcomes of Multimodal Prehabilitation with High Protein Oral and HMB Supplementation in Sarcopenic Surgical Patients: The HEROS Study
Nutrients · 2026
DOI: 10.3390/nu18040703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Irving Yu Le Shua und 31 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Sarcopenia, Valerates, Dietary Supplements, Preoperative Exercise. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council Clinical Trial Grant - Industry Collaborative Trials, National Medical Research Council Clinical Trial Grant – Industry Collaborative Trials.
Abstract (Originalsprache)
Background
Sarcopenia is associated with adverse surgical outcomes. Recent literature suggested that pre-surgery prehabilitation, nutrition and β-Hydroxy β-methylbutyric acid (HMB) supplementation improve myological and functional outcomes. However, long-term outcomes remain uncertain. Thus, we aimed to analyse findings from the long-term follow-up of surgical patients undergoing oral supplementation and prehabilitation.
Methods
A prospective single-centre pilot cohort study was conducted to evaluate the effects of multimodal prehabilitation using high-protein oral nutritional supplementation (HP-ONS) with HMB. Sarcopenic patients between 40 and 90 years old and undergoing gastrointestinal surgery were included from June 2022 to January 2024. Patients were followed up from two to four weeks pre-operatively to six months post-operatively. Paired Wilcoxon signed-rank tests were conducted to evaluate outcomes between time points.
Results
36 patients were included with a median age of 71.5 years (IQR: 55–90), and 50% were male. 12 (33.3%) patients were sarcopenic, while 24 (66.7%) were severely sarcopenic. No significant difference in IMAT% was observed at post-operative six months. Number of chair rise repetitions (Median:15 vs. 11, p < 0.001) and six-min walk test (Median: 387 m vs. 349 m, p = 0.020), mid-arm muscle circumference (Median: 23.7 cm vs. 22.5 cm, p = 0.013), mid-arm muscle area (Median: 44.8 cm2 vs. 39.3 cm2, p = 0.005), weight (Median: 51.6 kg vs. 50.8 kg, p = 0.023) and BMI (Median: 23.2 kg/m2 vs. 21.8 kg/m2, p = 0.025) increased significantly at six-months post-operatively from surgery.
Conclusions
Our findings suggest that improvements in anthropometric and functional outcomes from prehabilitation may persist beyond the acute recovery period. If supported by future works, multimodal prehabilitation has the potential to optimise postoperative recovery amongst sarcopenic older adult surgical patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
- Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore.
- SingHealth Duke-NUS Muscle Health Programme, Singapore 168582, Singapore.
- Department of Radiology, Sengkang General Hospital, Singapore 544886, Singapore.
- Department of Dietetics, Sengkang General Hospital, Singapore 544886, Singapore.
- Department of Physiotherapy, Sengkang General Hospital, Singapore 544886, Singapore.
ORCID-Profile: Irving Yu Le Shua, Yong Yi Tan, Jing Han Hong, Shawn Shi-Xian Kok, Cherie Tong, Clement C Yan, Lester Wei-Lin Ong, Koy-Min Chue, Nathanelle Ann Xiaolian Khoo, Frederick Hong-Xiang Koh
Förderung
- National Medical Research Council Clinical Trial Grant - Industry Collaborative Trials
- National Medical Research Council Clinical Trial Grant – Industry Collaborative Trials
Zitieren
APA
Shua, I. Y. L., Tan, Y. Y., Yik, V., Hong, J. H., Liu, Y. X., Chin, S. E., Kok, S. S., Lee, H. B., Tong, C., Tay, P., Chean, E., Lam, Y. E., Mah, S. M., Foo, L. X., Yan, C. C., Chua, W. T., Jamil, H. B., Ganesh, K., Ong, L. W., …, & Koh, F. H. (2026). Long-Term Outcomes of Multimodal Prehabilitation with High Protein Oral and HMB Supplementation in Sarcopenic Surgical Patients: The HEROS Study. Nutrients. https://doi.org/10.3390/nu18040703
Vancouver
Shua IYL, Tan YY, Yik V, Hong JH, Liu YX, Chin SE, et al. Long-Term Outcomes of Multimodal Prehabilitation with High Protein Oral and HMB Supplementation in Sarcopenic Surgical Patients: The HEROS Study. Nutrients. 2026. doi:10.3390/nu18040703
BibTeX
@article{Shua2026,
author = {Shua, Irving Yu Le and Tan, Yong Yi and Yik, Vanessa and Hong, Jing Han and Liu, Yun-Xia and Chin, Shuen-Ern and Kok, Shawn Shi-Xian and Lee, Hui-Bing and Tong, Cherie and Tay, Phoebe and Chean, Esther and Lam, Yi-En and Mah, Shi-Min and Foo, Li-Xin and Yan, Clement C and Chua, Wei-Tian and Jamil, Haziq Bin and Ganesh, Khasthuri and Ong, Lester Wei-Lin and Tan, Alvin Yong-Hui and Chue, Koy-Min and Ho, Leonard Ming-Li and Chong, Cheryl Xi-Zi and Ladlad, Jasmine and Tan, Cheryl Hui-Min and Khoo, Nathanelle Ann Xiaolian and Ng, Jia-Lin and Tan, Winson Jianhong and Foo, Fung-Joon and Teh, Bin Tean and Wang, Yibin and Koh, Frederick Hong-Xiang},
title = {Long-Term Outcomes of Multimodal Prehabilitation with High Protein Oral and HMB Supplementation in Sarcopenic Surgical Patients: The HEROS Study},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18040703}
}
EUVIMED